![Ryan Dunlap](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ryan Dunlap
Direktor/Vorstandsmitglied bei
CYTODYN INC.
Vermögen: - $ am 31.07.2026
Profil
Mr. Ryan M.
Dunlap, CPA, is an Independent Director at CytoDyn, Inc. and a Chief Financial Officer at Gurobi Optimization LLC.
He is on the Board of Directors at CytoDyn, Inc. Mr. Dunlap was previously employed as a Chief Operating Officer by MolecularMD Corp., a VP, Chief Financial & Accounting Officer by Galena Biopharma, Inc., a Vice President-Acquisitions by Industrial Income Trust, Inc., and a Chairman by Oregon Bioscience Association.
He received his undergraduate degree from the University of Oregon.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
CYTODYN INC. -.--% | 20.03.2026 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Ryan Dunlap
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTODYN INC. | Direktor/Vorstandsmitglied | 24.08.2022 |
Gurobi Optimization LLC
 Gurobi Optimization LLC Packaged SoftwareTechnology Services Develops decision intelligence software for businesses | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Ryan Dunlap
| Unternehmen | Position | Ende |
|---|---|---|
Oregon Bioscience Association
 Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services Operates as association that promotes researchers and entrepreneurs | Vorsitzender | 03.03.2021 |
Galena Biopharma, Inc.
 Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development | Finanzdirektor/CFO | 31.12.2015 |
MolecularMD Corp.
 MolecularMD Corp. Medical/Nursing ServicesHealth Services Develops and commercializes molecular diagnostics for oncology applications | Finanzdirektor/CFO | 01.12.2017 |
Industrial Income Trust, Inc.
 Industrial Income Trust, Inc. Investment Trusts/Mutual FundsMiscellaneous Open-End Investment Fund/Unit Trust | Corporate Officer/Principal | - |
Ausbildung von Ryan Dunlap
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
39
Beziehungen ersten Grades
7
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
CytoDyn, Inc.
 CytoDyn, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops and commercializes pharmaceutical products to treat human immunodeficiency virus infection | Health Technology |
Galena Biopharma, Inc.
Galena Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical products through biopharmaceutical research and development | Health Technology |
Industrial Income Trust, Inc.
Industrial Income Trust, Inc. Investment Trusts/Mutual FundsMiscellaneous Open-End Investment Fund/Unit Trust | Miscellaneous |
University of Oregon
 University of Oregon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MolecularMD Corp.
MolecularMD Corp. Medical/Nursing ServicesHealth Services Develops and commercializes molecular diagnostics for oncology applications | Health Services |
Oregon Bioscience Association
Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services Operates as association that promotes researchers and entrepreneurs | Commercial Services |
Gurobi Optimization LLC
Gurobi Optimization LLC Packaged SoftwareTechnology Services Develops decision intelligence software for businesses | Technology Services |
